Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ines Pires da Silva, MD, PhD, Melanoma Institute Australia and The University of Sydney, Sydney, Australia, outlines two large studies on mucosal and acral melanoma that were presented at ESMO 2021. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.
Disclosures
Dr da Silva reports travel support by BMS and MSD, and speaker fee by Roche, BMS, MSD and Novartis.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.